Research
Mixed
Sarcopenia is defined by a combination of muscle weakness, low muscle mass, and impaired physical performance (e.g., slow walking speed), with prevalence ranging from 4% to 27% in older populations.
Sarcopenia isn't just 'getting old'; it's a specific condition defined by weakness, low muscle mass, and slow walking. Screening for these metrics can help identify at-risk individuals for early intervention.
StrongSupportsVERY_HIGH confidence
the European Working Group on Sarcopenia in Older People has expanded the definition and suggested criteria for diagnosis including the presence of muscle weakness... a lower muscle mass... and the presence of impaired performance (slow walking speed). The prevalence of sarcopenia in the older population may range from 4% to 27% depending on the gender of the participants and country.
Why this rating
Review article citing consensus guidelines and large population studies.
Source
Aging of Skeletal Muscle Fibers
Nataša Miljković et al. · Annals of Rehabilitation Medicine · 2015
DOI 10.5535/arm.2015.39.2.155
narrative_reviewCited 302×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Aging skeletal muscle undergoes intrinsic quality decline (reduced force-generating capacity per unit size) due to myofilament alterations, excitation-contraction uncoupling, and mitochondrial dysfunction, independent of muscle mass loss.Good
- Aging is associated with a fast-to-slow muscle fiber type transformation (specifically IIx to I) and a reduction in type II fiber number and size, contributing to loss of power and strength.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →